The ATN1 gene gives cells instructions for a protein that helps control how other genes are switched on and off. If it does not work properly, brain cells may not function as they should. This gene plays an important role in keeping nerve cell activity balanced over time. A repeat expansion in the ATN1 gene causes dentatorubral-pallidoluysian atrophy, a rare inherited condition that can lead to movement problems, seizures, and changes in thinking or behavior. Other rare variants can also affect development and learning.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or manage processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do the work. Other genes mainly regulate when certain processes take place, where they happen, and how active they are. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
ATN1Gene function
What if the gene works
Your cells use the ATN1 gene to help control when other genes are switched on or off. This supports normal brain development and the day to day function of nerve cells.
Risk
What if the gene does not work
Variants in the ATN1 gene can affect the brain. Some cause progressive movement problems, seizures, and changes in thinking, while others cause developmental delay and low muscle tone; milder and severe variants can differ in onset and severity.
Treatment
What does that mean for your treatment
No treatment or management approach is currently tailored specifically to pathogenic variants in the ATN1 gene; care is based on symptoms and daily needs. The ATN1 gene is being studied as a possible target for gene-silencing treatments (treatments designed to lower harmful ATN1 activity), especially in dentatorubral-pallidoluysian atrophy.
Conditions associated with ATN1
Gene function
What if the gene works
Healthy cells need some genes to stay active and others to stay quiet. The ATN1 gene helps manage that balance during growth and everyday cell work. Its protein mainly works in the nucleus, where gene activity is organized. This core ATN1 gene function is especially important in the brain and other tissues that depend on careful timing.
Cells use the ATN1 gene to keep some genes more active and others quieter. Its protein joins control teams in the nucleus, the part of the cell that manages gene activity.
During growth, the ATN1 gene helps cells turn programs on and off at the right time. This supports orderly development in many tissues, including the brain.
Inside the nucleus, the ATN1 gene’s protein works alongside other control proteins rather than acting alone. This teamwork helps cells respond to routine signals in a coordinated way.
What is a variant?
A genetic variant is a slight alteration in the DNA sequence of a gene. These changes are common and form part of normal human diversity, including differences in appearance, metabolism, and how the body reacts to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ATN1 gene can change the shape, stability, or cell behavior of the atrophin-1 protein. The best known change is an expanded DNA repeat, which makes the protein too long, more likely to misfold, collect in the cell nucleus, and disrupt other proteins. This is how ATN1 gene variants affect protein function in many families. Larger repeat expansions often have a stronger effect and are linked to earlier onset and more marked symptoms.
How variants are linked to conditions
Pathogenic variants in the ATN1 gene are mainly linked to two rare neurologic conditions. An expanded repeat in the ATN1 gene causes dentatorubral-pallidoluysian atrophy, which can lead to seizures, movement problems, trouble with balance, and changes in thinking over time. Other variants cause CHEDDA syndrome, an ATN1 gene-related condition marked by low muscle tone, developmental delay, epilepsy, and differences of the fingers or toes.
A variant is not necessarily a diagnosis
Genetic variants are common and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ATN1, risk is mainly shaped by the specific gene change that is inherited, rather than by lifestyle or everyday exposures. In families with the repeat expansion linked to dentatorubral-pallidoluysian atrophy, a larger expansion often means a higher chance of symptoms and earlier onset, and the repeat can grow when passed down, especially from a father.
Inheritance of ATN1 variants
ATN1-related conditions are usually inherited in an autosomal dominant pattern, which means one changed copy of the ATN1 gene can be enough to cause the condition. In families where a parent carries a disease-causing ATN1 variant, each child has a 50% chance of inheriting it. How variants of the ATN1 gene are inherited can also include new, de novo variants, meaning the change starts in the child and was not passed down from either parent.
What does my ATN1 result mean for my family?
ATN1-related conditions are usually passed down in a dominant way, so close relatives such as parents, siblings, and children may also have the same genetic change. For many families, this means first-degree relatives may want to discuss whether testing would be helpful. The exact family impact depends on the specific ATN1 result, because some changes are inherited while others can happen for the first time in one person.
Genetic information
Genetic testing
How you find out about variants
ATN1 genetic testing uses a blood or saliva sample to look for changes in the ATN1 gene. A lab may use DNA sequencing to find small variants and, when needed, a separate repeat expansion test to measure extra CAG repeats that standard sequencing may miss. Results can show whether an ATN1-related condition has been genetically confirmed.
When should I consider getting a genetic test?
Consider ATN1 testing if there is a family history of DRPLA, an inherited brain condition that can cause worsening movement problems, seizures, and changes in thinking or mood. It may also be considered for a child with marked developmental delay, low muscle tone, and feeding or breathing problems that suggest an ATN1-related condition.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies based on the condition and the specific variant involved. Over time, the way the body functions is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds at the drug’s target. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences shape the way people respond to medicines. By studying links between genes and medications, it helps explain why the same treatment can affect one person differently than another. For many drugs, genes influence both how strongly a medicine works and how the body handles it. This information can support treatment decisions that are better informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the ATN1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so any questions about symptoms, side effects, or treatment changes are best discussed with your doctor.
History
ATN1 entered medical genetics through studies of families affected by dentatorubral-pallidoluysian atrophy, a rare inherited neurologic condition first described in Japan. In the early 1990s, researchers linked the condition to chromosome 12, narrowing the search to a specific region of DNA. Building on this early work, scientists identified the ATN1 gene in 1994 and showed that an expanded CAG repeat within the gene was the cause in affected families. This placed ATN1 among the first genes tied to a growing group of repeat expansion conditions, which reshaped how inherited neurologic diseases were understood. The way this gene was viewed has shifted over time, especially as later work connected different ATN1 variants with additional developmental and neurologic conditions.